[Biomarker screening for early detection of cancer].

Autor:	Wiedemann GJ; Klinik für Innere Medizin, Gastroenterologie und Onkologie, Oberschwabenklinik, St. Elisabeth, Ravensburg. guenther.wiedemann@oberschwabenklinikmann@oberschwabenklinik.de
Jazyk:	němčina
Zdroj:	Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2013 Jan; Vol. 138 (1-2), pp. 43-5. Date of Electronic Publication: 2012 Dec 18.
DOI:	10.1055/s-0032-1327370
Abstrakt:	The question of when a certain concentration of a serum biomarker turns into a tumor marker, i. e. an objectively verifiable criterion for tumor diagnosis, leads to the analysis of the specificity (a measure of the proportion of correctly identified healthy individuals), sensitivity (a measure of the proportion of correctly recognized cancer patients), and precision (positive predictive value). Or in short: a tumor marker is specific if no healthy individual has one. This constitutes the problem: The serum concentrations of biomarkers of cancer patients and healthy subjects overlap. Healthy individuals occasionally have "tumor markers" and cancer patients in turn sometimes express inconspicuous biomarkers. (© Georg Thieme Verlag KG Stuttgart · New York.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu